209 related articles for article (PubMed ID: 18922899)
1. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics.
Waalkes MP; Liu J; Germolec DR; Trempus CS; Cannon RE; Tokar EJ; Tennant RW; Ward JM; Diwan BA
Cancer Res; 2008 Oct; 68(20):8278-85. PubMed ID: 18922899
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
3. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers.
Waalkes MP; Ward JM; Diwan BA
Carcinogenesis; 2004 Jan; 25(1):133-41. PubMed ID: 14514661
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
[TBL] [Abstract][Full Text] [Related]
5. Transplacental arsenic carcinogenesis in mice.
Waalkes MP; Liu J; Diwan BA
Toxicol Appl Pharmacol; 2007 Aug; 222(3):271-80. PubMed ID: 17306315
[TBL] [Abstract][Full Text] [Related]
6. Non-melanoma skin cancer in mouse and man.
Schwarz M; Münzel PA; Braeuning A
Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
[TBL] [Abstract][Full Text] [Related]
7. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.
Germolec DR; Spalding J; Yu HS; Chen GS; Simeonova PP; Humble MC; Bruccoleri A; Boorman GA; Foley JF; Yoshida T; Luster MI
Am J Pathol; 1998 Dec; 153(6):1775-85. PubMed ID: 9846968
[TBL] [Abstract][Full Text] [Related]
8. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
[TBL] [Abstract][Full Text] [Related]
9. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
Trempus CS; Haseman JK; Tennant RW
Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
[TBL] [Abstract][Full Text] [Related]
10. Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver.
Liu J; Xie Y; Merrick BA; Shen J; Ducharme DM; Collins J; Diwan BA; Logsdon D; Waalkes MP
Toxicol Appl Pharmacol; 2006 Jun; 213(3):216-23. PubMed ID: 16368122
[TBL] [Abstract][Full Text] [Related]
11. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
[TBL] [Abstract][Full Text] [Related]
12. Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.
Zhang Z; Diwan BA; Anderson LM; Logsdon D; Olivero OA; Haines DC; Rice JM; Yuspa SH; Poirier MC
Mol Carcinog; 1998 Sep; 23(1):45-51. PubMed ID: 9766437
[TBL] [Abstract][Full Text] [Related]
13. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.
Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW
Carcinogenesis; 2001 Apr; 22(4):651-9. PubMed ID: 11285202
[TBL] [Abstract][Full Text] [Related]
15. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
16. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors.
Germolec DR; Spalding J; Boorman GA; Wilmer JL; Yoshida T; Simeonova PP; Bruccoleri A; Kayama F; Gaido K; Tennant R; Burleson F; Dong W; Lang RW; Luster MI
Mutat Res; 1997 Jun; 386(3):209-18. PubMed ID: 9219559
[TBL] [Abstract][Full Text] [Related]
17. Arsenic, stem cells, and the developmental basis of adult cancer.
Tokar EJ; Qu W; Waalkes MP
Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S192-203. PubMed ID: 21071725
[TBL] [Abstract][Full Text] [Related]
18. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene.
Blessing M; Nanney LB; King LE; Hogan BL
Teratog Carcinog Mutagen; 1995; 15(1):11-21. PubMed ID: 7604388
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion.
Meyer SA; Kim TW; Moser GJ; Monteiro-Riviere NA; Smart RC
Carcinogenesis; 1994 Jan; 15(1):47-52. PubMed ID: 8293547
[TBL] [Abstract][Full Text] [Related]
20. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.
Hansen LA; Tennant R
Mol Carcinog; 1994 Mar; 9(3):143-54. PubMed ID: 7908201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
